Evidence map›Paper›PMID 32222555›Full record

ArticleNeuroscience2020

A Role for PGC-1α in Transcription and Excitability of Neocortical and Hippocampal Excitatory Neurons.

L J McMeekin, A F Bartley, A S Bohannon, E W Adlaf, T van Groen, S M Boas, S N Fox, P J Detloff, D K Crossman, L S Overstreet-Wadiche and 3 more

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. A brain-specificLife science alliance · 2021
    Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

L J McMeekinDepartment of Neuroscience, Drug Discovery Division at Southern Research, Birmingham, AL 35205, USA; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
A F BartleyDepartment of Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
A S BohannonDepartment of Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
E W AdlafDepartment of Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
T van GroenDepartment of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
S M BoasDepartment of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
S N FoxDepartment of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
P J DetloffDepartment of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
D K CrossmanDepartment of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
L S Overstreet-WadicheDepartment of Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
J J HablitzDepartment of Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
L E DobrunzDepartment of Neurobiology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
R M CowellDepartment of Neuroscience, Drug Discovery Division at Southern Research, Birmingham, AL 35205, USA; Department of Cell, Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. Electronic address: rcowell@southernresearch.org.
University of Alabama at Birmingham · USSouthern Research Institute · US

Funding

UAB Neuroscience Core CenterP30NS047466 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HABLITZ, JOHN J. · 2005 to 2019
$8.5M
Newborn Neurons in the Adult Hippocampal NetworkR01NS064025 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OVERSTREET-WADICHE, LINDA · 2009 to 2023
$5.6M
Transcriptional regulation of metabolism in neuronsR01NS101958 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI COWELL, RITA MARIE · 2017 to 2021
$2.1M
Inhibitory Neural Circuits in Dentate FunctionR01NS105438 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI OVERSTREET-WADICHE, LINDA · 2018 to 2022
$2.1M
Interneuron Dysfunction Alters the Dynamics of the Inhibition-Excitation BalanceR01MH098534 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DOBRUNZ, LYNN E · 2012 to 2016
$1.8M
UAB Training Program In NeuroscienceT32NS095775 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Erik D Roberson · 2017 to 2026
$1.6M
PGC-1alpha and GABAergic Dysfunction in Huntington DiseaseR01NS070009 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI COWELL, RITA MARIE · 2010 to 2014
$1.4M
Transcriptional Regulation of Metabolism in SchizophreniaK01MH077955 · NIMH · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI COWELL, RITA MARIE · 2007 to 2011
$661k
NIMH NIH HHS K01 MH077955NIMH NIH HHS R01 MH098534NINDS NIH HHS P30 NS047466NINDS NIH HHS R01 NS064025NINDS NIH HHS R01 NS070009NINDS NIH HHS R01 NS101958NINDS NIH HHS R01 NS105438NINDS NIH HHS T32 NS095775
6 · The paper itself

Abstract

The transcriptional coactivator peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) is a critical regulator of genes involved in neuronal metabolism, neurotransmission, and morphology. Reduced PGC-1α expression has been implicated in several neurological and psychiatric disorders. An understanding of PGC-1α's roles in different cell types will help determine the functional consequences of PGC-1α dysfunction and/or deficiency in disease. Reports from our laboratory and others suggest a critical role for PGC-1α in inhibitory neurons with high metabolic demand such as fast-spiking interneurons. Here, we document a previously unrecognized role for PGC-1α in maintenance of gene expression programs for synchronous neurotransmitter release, structure, and metabolism in neocortical and hippocampal excitatory neurons. Deletion of PGC-1α from these neurons caused ambulatory hyperactivity in response to a novel environment and enhanced glutamatergic transmission in neocortex and hippocampus, along with reductions in mRNA levels from several PGC-1α neuron-specific target genes. Given the potential role for a reduction in PGC-1α expression or activity in Huntington Disease (HD), we compared reductions in transcripts found in the neocortex and hippocampus of these mice to that of an HD knock-in model; few of these transcripts were reduced in this HD model. These data provide novel insight into the function of PGC-1α in glutamatergic neurons and suggest that it is required for the regulation of structural, neurosecretory, and metabolic genes in both glutamatergic neuron and fast-spiking interneuron populations in a region-specific manner. These findings should be considered when inferring the functional relevance of changes in PGC-1α gene expression in the context of disease.

Indexed as

NeocortexAnimalsHippocampusInterneuronsMiceMice, KnockoutNeuronsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphabehaviorelectrophysiologyPGC-1αpyramidal neuronstranscription

Identifiers

PMID32222555
PMCPMC7325608
OpenAlexW3013450261

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.